These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 8105805)

  • 1. Immunobiological aspects of HIV treatment.
    Dalgleish AG
    Curr Opin Immunol; 1993 Aug; 5(4):608-14. PubMed ID: 8105805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV immunotherapy comes of age: implications for prevention, treatment and cure.
    Routy JP; Mehraj V; Cao W
    Expert Rev Clin Immunol; 2016; 12(2):91-4. PubMed ID: 26629806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV infection and AIDS.
    Shearer WT
    Prim Care; 1998 Dec; 25(4):759-74. PubMed ID: 9735117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A strategy for prophylactic vaccination against HIV.
    Salk J; Bretscher PA; Salk PL; Clerici M; Shearer GM
    Science; 1993 May; 260(5112):1270-2. PubMed ID: 8098553
    [No Abstract]   [Full Text] [Related]  

  • 5. HIV-Tat immunization induces cross-clade neutralizing antibodies and CD4(+) T cell increases in antiretroviral-treated South African volunteers: a randomized phase II clinical trial.
    Ensoli B; Nchabeleng M; Ensoli F; Tripiciano A; Bellino S; Picconi O; Sgadari C; Longo O; Tavoschi L; Joffe D; Cafaro A; Francavilla V; Moretti S; Pavone Cossut MR; Collacchi B; Arancio A; Paniccia G; Casabianca A; Magnani M; Buttò S; Levendal E; Ndimande JV; Asia B; Pillay Y; Garaci E; Monini P;
    Retrovirology; 2016 Jun; 13(1):34. PubMed ID: 27277839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential pitfalls on the road to an effective HIV vaccine.
    Schwartz DH
    Immunol Today; 1994 Feb; 15(2):54-7. PubMed ID: 7908803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AIDS vaccines. Immune Response Corp.--take two.
    Cohen J
    Science; 1994 Jun; 264(5164):1402. PubMed ID: 7910980
    [No Abstract]   [Full Text] [Related]  

  • 8. Toward an understanding of the correlates of protective immunity to HIV infection.
    Haynes BF; Pantaleo G; Fauci AS
    Science; 1996 Jan; 271(5247):324-8. PubMed ID: 8553066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soluble mediators of inflammation in HIV and their implications for therapeutics and vaccine development.
    Keating SM; Jacobs ES; Norris PJ
    Cytokine Growth Factor Rev; 2012; 23(4-5):193-206. PubMed ID: 22743035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Destructive networks in AIDS.
    Kennedy JR
    Immunol Today; 1993 Dec; 14(12):615. PubMed ID: 7905741
    [No Abstract]   [Full Text] [Related]  

  • 11. Immune responses and reconstitution in HIV-1 infected individuals: impact of anti-retroviral therapy, cytokines and therapeutic vaccination.
    Imami N; Hardy G; Burton C; Pires A; Pido-Lopez J; Moss R; Gazzard B; Gotch F
    Immunol Lett; 2001 Nov; 79(1-2):63-76. PubMed ID: 11595291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune interventions in HIV infection.
    Carcelain G; Autran B
    Immunol Rev; 2013 Jul; 254(1):355-71. PubMed ID: 23772631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV Susceptibility of human antigen-specific CD4 T cells in AIDS pathogenesis and vaccine response.
    Hu H; Liu F; Kim J; Ratto-Kim S
    Expert Rev Vaccines; 2016 Jun; 15(6):709-17. PubMed ID: 26814372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Animal models for the study of human immunodeficiency virus infections.
    Letvin NL
    Curr Opin Immunol; 1992 Aug; 4(4):481-5. PubMed ID: 1356349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cellular immune responses in asymptomatic human immunodeficiency virus type 1 (HIV-1) infection and effects of vaccination with recombinant envelope glycoprotein of HIV-1.
    Gorse GJ; Simionescu RE; Patel GB
    Clin Vaccine Immunol; 2006 Jan; 13(1):26-32. PubMed ID: 16425996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV-1 Reservoir Dynamics after Vaccination and Antiretroviral Therapy Interruption Are Associated with Dendritic Cell Vaccine-Induced T Cell Responses.
    Andrés C; Plana M; Guardo AC; Alvarez-Fernández C; Climent N; Gallart T; León A; Clotet B; Autran B; Chomont N; Gatell JM; Sánchez-Palomino S; García F
    J Virol; 2015 Sep; 89(18):9189-99. PubMed ID: 26109727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Control of viremia and prevention of clinical AIDS in rhesus monkeys by cytokine-augmented DNA vaccination.
    Barouch DH; Santra S; Schmitz JE; Kuroda MJ; Fu TM; Wagner W; Bilska M; Craiu A; Zheng XX; Krivulka GR; Beaudry K; Lifton MA; Nickerson CE; Trigona WL; Punt K; Freed DC; Guan L; Dubey S; Casimiro D; Simon A; Davies ME; Chastain M; Strom TB; Gelman RS; Montefiori DC; Lewis MG; Emini EA; Shiver JW; Letvin NL
    Science; 2000 Oct; 290(5491):486-92. PubMed ID: 11039923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Indirect mechanisms of HIV pathogenesis: how does HIV kill T cells?
    Finkel TH; Banda NK
    Curr Opin Immunol; 1994 Aug; 6(4):605-15. PubMed ID: 7946050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent developments in theories of pathogenesis of AIDS.
    Antia R; Halloran ME
    Trends Microbiol; 1996 Jul; 4(7):282-5. PubMed ID: 8829337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Programmed cell death and AIDS pathogenesis: significance and potential mechanisms.
    Ameisen JC; Estaquier J; Idziorek T; De Bels F
    Curr Top Microbiol Immunol; 1995; 200():195-211. PubMed ID: 7634833
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.